For discharged patients without suspected or confirmed VTE or other indication for anticoagulation, panel suggests not using anticoagulants.
Intermediate anticoagulation doses appear to be safe and effective as thromboprophylaxis in patients with high thrombotic risk active cancer.
Researchers sought to determine whether corticosteroids would be an effective treatment for patients with chemotherapy-induced thrombocytopenia.
Researchers sought to determine whether patients with cancer who had COVID-19 had an increased risk of experiencing thromboembolic events.
Researchers sought to identify the experiences of patients who developed prothrombotic immune thrombocytopenia after receiving the ChAdOx1 vaccine (AZD1222) against SARS-CoV-2.
The AHA has issued a Presidential Advisory Statement outlining considerations for addressing the effects of opioids on cardiovascular and neurovascular health.
No individual risk factors identified for VITT, but increased mortality seen for those with cerebral venous sinus thrombosis, low platelets.
Single, postoperative IV dose of abelacimab superior to enoxaparin for preventing venous thromboembolism, with no increase in bleeding risk.
Researchers sought to describe the unexpected autoimmune prothrombotic disorder experienced after vaccination with the ChAdOx1 COVID-19 vaccine.
Disparities seen among VA patients both for initiating any anticoagulant therapy and for initiating direct-acting oral anticoagulant use.
Researchers sought to determine the mortality rate for pediatric patients with COVID-19 or multisystem inflammatory syndrome in children who experience thrombotic events.
Venous thromboembolism occurred less often for those with Crohn disease versus ulcerative colitis
A panel convened to develop guidelines for management of venous thromboembolism in the Latin American region.
Hospitalized patients with COVID-19 had a greater than 3-fold adjusted risk for venous thromboembolism compared with matched controls, the study found.
In a meta-analysis, researchers sought to further clarify the role of oral anticoagulation for preventing ischemic stroke in patients with AF and HFrEF.
Researchers sought to determine the mechanism through which hyperhomocysteinemia contributes to thrombosis, directly and indirectly activating platelets.
Researchers sought to identify aspects of the disease course and risk factors involved with extrahepatic portal vein thrombosis (EHPVT) in pediatric patients.
Researchers sought to determine the link between lung ultrasound findings and the development of VTE in patients with COVID-19.
A novel study asks: Does a correlation exist between preexisting comorbidities and serum titers of anti-BP180 and 230 antibodies in patients with bullous pemphigoid (BP)?
Using data from the French National TMA registry, study authors evaluated the demographic and clinical characteristics of thrombotic microangiopathy in autoimmune diseases, and assessed therapeutic approaches.
Researchers sought to determine the rates of VTE and major bleeding in patients with glioblastoma.
Researcher sought to determine the risk of developing VTE in patients with and without COVID-19 who were hospitalized.
Researchers sought to determine whether CDKN2A deletion could predict a higher risk of VTE in patients with glioblastoma.
Researchers evaluated the NEOCLOT protocol for management of catheter-related venous thrombosis in neonates in the Netherlands.
Number of clot retrieval attempts linked to infarct growth, which independently predicts unfavorable outcome in acute ischemic stroke.
Researchers sought to determine the occurrence of thrombotic events in a cohort of pediatric patients with myeloproliferative neoplasms.
Researchers described outcomes for 3 patients in Canada who were treated with high-dose IVIG for vaccine-induced immune thrombotic thrombocytopenia after receiving the ChAdOx1 nCoV-19 vaccine.
Researchers sought to determine whether patients with anemia had an increased risk of ischemic stroke and poststroke mortality.
Researchers sought to determine whether patients with reduced calf muscle pump function may be at an increased risk for venous thromboembolism.
This meta-analysis included patients with stroke and/or transient ischemic attacks to determine whether women are under-represented in clinical trials of acute stroke therapies.
A team of investigators evaluated the lifetime outcomes linked to the speed of endovascular thrombectomy success in patients with acute ischemic stroke.
Pradaxa oral pellets are supplied in child-resistant packets in 20mg, 30mg, 40mg, 50mg, 110mg, and 150mg dosage strengths.
Researchers sought to determine the risk of thrombotic complications in patients with cancer who have a newly inserted central venous catheter.
Researchers sought to determine whether a novel CWA-small amount tissue factor-induced clotting factor IX assay could detect hemostatic abnormalities after surgery.
A team of investigators conducted a population-based cohort study to determine whether preeclampsia history affected the relative risk for incident stroke.
Researchers sought to determine methods for diagnosing and managing patients who develop coagulation disorders due to COVID-19 infection.
Researchers sought to determine whether anticoagulation would be effective at preventing PE for patients with id-DVT.
Researchers sought to determine whether patients with HCC who develop PVTT would benefit from alternative treatments to systemic therapy.
Researchers sought to determine the long-term safety and efficacy of fostamatinib for treating patients with immune thrombocytopenia and rheumatoid arthritis.
Researchers sought to identify and analyze risk factors for thrombosis in adolescent girls receiving hormonal therapy.
Researchers sought to determine whether thromboprophylaxis may help treat patients with POTS to reduce CVC-related thrombosis.
Researchers sought to determine if there would be similar results for bleeding rates in pediatric patients with cancer and VTE who received either DOACs or LMWH.
Wei Xiong, MD, PhD, sought to outline and clarify the current state of managing venous thromboembolism in patients with cancer.
Immune checkpoint inhibitor therapy may be linked to increased risk of thromboembolic events, particularly venous thromboembolism, in patients with cancer.
Researchers sought to determine whether there was a difference between venous repairs or ligation in rates of DVT or PE in patients with lower extremity venous injury.
At the 2021 International Stroke Conference, researchers presented their findings on the differences in poststroke depression between elderly men and women.
Researchers investigated the clinical and safety outcomes of mechanical thrombectomy for isolated posterior circulation DMVO stroke and compared them with standard medical treatment.
Britain’s medical regulatory agency has received 30 reports of clotting events after people were vaccinated.
Researchers sought to determine whether rivaroxaban may be superior to low-molecular-weight heparin for reducing all-cause mortality.
Researchers are examining the role of platelets as drivers of inflammation, which may provide a mechanistic link with ischemia-reperfusion injury.
This the first study to evaluate the risk for venous thromboembolism by lupus nephritis class, according to investigators.